SlideShare a Scribd company logo
1 of 13
How Long Before the Clinical Diagnosis of
  Heart Failure are HF Signs and Symptoms
  First Documented in the Medical Record?
    Steven R. Steinhubl, Jimeng Sun, Roy J. Byrd, Zahra Daar, Rajakrishnan
            Vijayakrishnan, Shahram Ebadollahi, Walter F. Stewart
Geisinger Medical Center, Danville, PA and IBM T.J. Watson Research Center,
                              Hawthorne, NY
Heal • Teach • Discover • Serve
Background
 • Decompensated HF is the leading cause of hospital
   admissions for US Medicare patients.
 • Therapeutic interventions exist for the HF patient that
   have been proven to reduce HF admissions by ~33%
   and decrease mortality by up to ~50%.
 • The diagnosis of HF in the primary care population is
   challenging:
       – Primary care physicians feel uncomfortable making a HF
         diagnosis1.
       – False-positive diagnosis in over 30%2, and false negative in
         over 20% of elderly COPD patients3.
       – There is marked variability, even among cardiologists, as to
         what findings are considered diagnostic for HF4.
     1BMJ    2003;326(7382):196     2Eur Heart J 1991; 12: 315-321   3BMJ   2005; 26:1887-94
                                  4J Am Coll Cardiol 1986;8:966-70
Heal • Teach • Discover • Serve
Background
 • A better understanding of the time course of the
   earliest clinical manifestations of HF may help
   improve the earlier diagnosis of the HF patient.
 • The limited available
   data evaluating the
   onset of HF signs
   and symptoms have
   focused only on the
   days to weeks
   preceding an acute
   HF exacerbation.
Am J Med. 2003;114:625–630
Heal • Teach • Discover • Serve
Objective


            Identify the time course for the
       presentation of HF signs and symptoms
        in the months to years preceding a HF
        diagnosis through the application of a
             sophisticated natural language
      processing protocol to longitudinal EHRs
          in a large primary care population.


Heal • Teach • Discover • Serve
Methods
• The dataset used for this project consisted of the full
  records for 50,625 patients followed in the primary
  care network of the GHS, consisting of 4,644 cases and
  45,981 group-matched controls.
• The features used for machine learning include
  assertions and denials of Framingham HF criteria.
• Extracted by text mining tools consisting of a pipeline
  of dictionary, grammar and text analysis engines
  developed and deployed within the UIMA system.
• In total, there are over 3.3 million clinical notes, with a
  total of 4,484,666 Framingham criteria mentions;
  892,805 of these were affirmed criteria.
Heal • Teach • Discover • Serve
Methods – Framingham Criteria
              MAJOR SYMPTOMS                                 MINOR SYMPTOMS
 1. Paroxysmal Nocturnal Dyspnea                   1. Bilateral Ankle Edema
     (PND) or Orthopnea
 2. Neck Vein Distension (JVD)                     2. Nocturnal Cough
 3. Rales                                          3. Dyspnea on ordinary exertion
 4. Radiographic Cardiomegaly                      4. Hepatomegaly
 5. Acute Pulmonary Edema                          5. Pleural effusion
                                                   6. A decrease in vital capacity by 1/3 of
 6. S3 Gallop
                                                       the maximal value recorded
 7. Increased Central Venous Pressure              7. Tachycardia (>120 BPM)
      (> 16 cm H2O at RA)
 8. Circulation Time of 25 seconds
                                                   * Not utilized in this analysis as not
 9. Hepatojugular Reflux (HJR)
                                                     documented in routine clinical
 10.Weight loss 4.5kg in 5 days in                   practice.
    response to treatment
Heal • Teach • Discover • Serve   N Engl J Med. 1971;285:1441-1446.
Results – Patient Characteristics
                                           Cases (N=4,644)
              Mean Age (years)                  70.9
              Female (%)                        48.4
              EF < 50% (%)                      45.3
              Hypertension (%)                  61.9
              Diabetes (%)                      31.8
              Known CAD (%)                     25.5
              Valvular Heart Disease (%)         4.2
              COPD (%)                          18.4
              Chronic Kidney Disease (%)         4.4


Heal • Teach • Discover • Serve
Results: Average Days Prior to Clinical
       Diagnosis of Criterion Documentation
                                  # of Patients in Whom Criteria      Average # of Days
                                  were Identified Prior to Clinical    Prior to Clinical
                                            Diagnosis                     Diagnosis
Ankle Edema                                 3875 (83%)                        238
PND                                         1691 (36%)                        210
Dyspnea on
                                            3840 (83%)                       200
Exertion
Rales                                       1410 (30%)                       133
Radiographic
                                            1207 (26%)                       83
Cardiomegaly
JVD                                          549 (12%)                       77
Night Cough                                  374 (8%)                        53
Tachycardia                                  409 (9%)                        45
Pleural Effusion                             772 (17%)                       43
Hepatomegaly                                 246 (5%)                        38
S3 Gallop                                    130 (3%)                        18
Weight Loss                                  151 (3%)                        15
Heal • Teach • Discover • Serve
Results: Percentage of Patients with Select Criterion
     in the 4 Years Prior to Clinical Diagnosis
                                                                     Year 4         Year 3        Year 2        Year 1
                                    70
Percent with Criterion Documented




                                                                                                                       65
                                    60                        62.3
                                           Mean
                                          238 Days                                                   Mean
                                    50                                                              200 Days
                                                       49.5
                                                                                                                45.3
                                    40
                                                36.7
                                                                                                           34
                                    30

                                         25.2
                                    20                                                              23.2
                                                                          Mean                                                 Mean            17.9
                                                                         210 Days          17.2
                                                                                                                              133 Days
                                    10                                              11.3                                                10.1
                                                                              8.4                                                 7.3
                                                                        6.2                                                 5.2
                                     0
                                         Ankle Edema                          PND                          DOE                    Rales

                 Heal • Teach • Discover • Serve
Limitations

• Text and data mining are not perfect in their
  ability to recognize and appropriately label
  Framingham criteria. (overall F-score ~0.93)
• There is substantial variability in whether and
  how various clinicians document HF signs and
  symptoms.




Heal • Teach • Discover • Serve
Summary
• This is the first study we are aware of to
  identify the prevalence and timing of onset of
  HF signs and symptoms in the months to
  years preceding a clinical HF diagnosis.
• In many HF patients the signs and symptoms
  of HF are first documented well before clinical
  diagnosis; on average > 6 months.
• These results suggest that automated text and
  data mining of the EHR may play an important
  role in the earlier identification of the HF
  patient in the primary care setting.
Heal • Teach • Discover • Serve
Ongoing Work: Matrix Presentation of
  Symptom / Sign Co-occurrence
Ongoing Work: Outflow Graph of
Relationships Between Different Criterion

More Related Content

What's hot

What's hot (8)

Jolly S 201111
Jolly S 201111Jolly S 201111
Jolly S 201111
 
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
 
Resolute International 09.21
Resolute International 09.21Resolute International 09.21
Resolute International 09.21
 
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
 
Tct surya dharma
Tct surya dharmaTct surya dharma
Tct surya dharma
 
Adressing Radial Artery Spasm
Adressing Radial Artery SpasmAdressing Radial Artery Spasm
Adressing Radial Artery Spasm
 
BioNIR/EluNIR eDES: 1 Year Outcomes of BIONICS and NIREUS studies
BioNIR/EluNIR eDES: 1 Year Outcomes of BIONICS and NIREUS studiesBioNIR/EluNIR eDES: 1 Year Outcomes of BIONICS and NIREUS studies
BioNIR/EluNIR eDES: 1 Year Outcomes of BIONICS and NIREUS studies
 
MCC 2011 - Slide 5
MCC 2011 - Slide 5MCC 2011 - Slide 5
MCC 2011 - Slide 5
 

Similar to How Long Before the Clinical Diagnosis of Heart Failure are HF Signs and Symptoms First Documented in the Medical Record STEINHUBL

Aristotle presenter-wallentin-slides
Aristotle presenter-wallentin-slidesAristotle presenter-wallentin-slides
Aristotle presenter-wallentin-slidesAlejandro Panaro
 
Tomotherapy Based Image Guided Imrt
Tomotherapy Based Image  Guided ImrtTomotherapy Based Image  Guided Imrt
Tomotherapy Based Image Guided Imrtfondas vakalis
 
Non Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxNon Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxhospital
 
ACC 2013 what did we learn
ACC 2013 what did we learnACC 2013 what did we learn
ACC 2013 what did we learnhospital
 
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Sergio Pinski
 
CRRT Principles (Thai).pdf
CRRT Principles (Thai).pdfCRRT Principles (Thai).pdf
CRRT Principles (Thai).pdfjustlim
 
2-Fred-Finkelstein-Bosnia-PD-elderl_y.ppt
2-Fred-Finkelstein-Bosnia-PD-elderl_y.ppt2-Fred-Finkelstein-Bosnia-PD-elderl_y.ppt
2-Fred-Finkelstein-Bosnia-PD-elderl_y.pptsjamsulbahri3
 
Journal club 11 1-2012 woest trial
Journal club 11 1-2012 woest trialJournal club 11 1-2012 woest trial
Journal club 11 1-2012 woest trialMichael Katz
 
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...Joris van Dijk
 
Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.
Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.
Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.Fundacion EPIC
 
Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)fondas vakalis
 
The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...
The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...
The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...Health Informatics New Zealand
 
DOSE VF.pptx
DOSE VF.pptxDOSE VF.pptx
DOSE VF.pptxArunDeva8
 
Residual renal function.dr.Golper
Residual renal function.dr.GolperResidual renal function.dr.Golper
Residual renal function.dr.GolperNickolai Smirnov
 
Emergency rt for nurse
Emergency rt for nurseEmergency rt for nurse
Emergency rt for nursetechno UCH
 
Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...
Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...
Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...HMO Research Network
 

Similar to How Long Before the Clinical Diagnosis of Heart Failure are HF Signs and Symptoms First Documented in the Medical Record STEINHUBL (20)

Resolute international 09 21
Resolute international 09 21Resolute international 09 21
Resolute international 09 21
 
OOG/ZOG: Van huet foveal sparing in patienten met m. stargardt
OOG/ZOG: Van huet   foveal sparing in patienten met m. stargardtOOG/ZOG: Van huet   foveal sparing in patienten met m. stargardt
OOG/ZOG: Van huet foveal sparing in patienten met m. stargardt
 
Lancelot acs final
Lancelot acs finalLancelot acs final
Lancelot acs final
 
Aristotle presenter-wallentin-slides
Aristotle presenter-wallentin-slidesAristotle presenter-wallentin-slides
Aristotle presenter-wallentin-slides
 
Tomotherapy Based Image Guided Imrt
Tomotherapy Based Image  Guided ImrtTomotherapy Based Image  Guided Imrt
Tomotherapy Based Image Guided Imrt
 
Non Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxNon Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptx
 
ACC 2013 what did we learn
ACC 2013 what did we learnACC 2013 what did we learn
ACC 2013 what did we learn
 
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
 
CRRT Principles (Thai).pdf
CRRT Principles (Thai).pdfCRRT Principles (Thai).pdf
CRRT Principles (Thai).pdf
 
2-Fred-Finkelstein-Bosnia-PD-elderl_y.ppt
2-Fred-Finkelstein-Bosnia-PD-elderl_y.ppt2-Fred-Finkelstein-Bosnia-PD-elderl_y.ppt
2-Fred-Finkelstein-Bosnia-PD-elderl_y.ppt
 
Journal club 11 1-2012 woest trial
Journal club 11 1-2012 woest trialJournal club 11 1-2012 woest trial
Journal club 11 1-2012 woest trial
 
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
 
Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.
Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.
Fundación EPIC _ Tendencias actuales en TAVI y desafíos futuros.
 
Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)
 
The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...
The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...
The Caring Does Matter (CDM) Initiative: To Improve Cardiovascular Medication...
 
DOSE VF.pptx
DOSE VF.pptxDOSE VF.pptx
DOSE VF.pptx
 
Residual renal function.dr.Golper
Residual renal function.dr.GolperResidual renal function.dr.Golper
Residual renal function.dr.Golper
 
Emergency rt for nurse
Emergency rt for nurseEmergency rt for nurse
Emergency rt for nurse
 
Computers in Primary Care: Evolution or Revolution
Computers in Primary Care: Evolution or RevolutionComputers in Primary Care: Evolution or Revolution
Computers in Primary Care: Evolution or Revolution
 
Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...
Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...
Multi Institutional Cohort to Facilitate Cardiovascular Disease Biomarker Val...
 

More from HMO Research Network

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...HMO Research Network
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...HMO Research Network
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...HMO Research Network
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...HMO Research Network
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERHMO Research Network
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...HMO Research Network
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...HMO Research Network
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...HMO Research Network
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...HMO Research Network
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONHMO Research Network
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...HMO Research Network
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKHMO Research Network
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...HMO Research Network
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...HMO Research Network
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...HMO Research Network
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...HMO Research Network
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...HMO Research Network
 
Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...HMO Research Network
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEHMO Research Network
 

More from HMO Research Network (20)

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
 
From Populations to Patients
From Populations to PatientsFrom Populations to Patients
From Populations to Patients
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSON
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...
 
Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
 

How Long Before the Clinical Diagnosis of Heart Failure are HF Signs and Symptoms First Documented in the Medical Record STEINHUBL

  • 1. How Long Before the Clinical Diagnosis of Heart Failure are HF Signs and Symptoms First Documented in the Medical Record? Steven R. Steinhubl, Jimeng Sun, Roy J. Byrd, Zahra Daar, Rajakrishnan Vijayakrishnan, Shahram Ebadollahi, Walter F. Stewart Geisinger Medical Center, Danville, PA and IBM T.J. Watson Research Center, Hawthorne, NY Heal • Teach • Discover • Serve
  • 2. Background • Decompensated HF is the leading cause of hospital admissions for US Medicare patients. • Therapeutic interventions exist for the HF patient that have been proven to reduce HF admissions by ~33% and decrease mortality by up to ~50%. • The diagnosis of HF in the primary care population is challenging: – Primary care physicians feel uncomfortable making a HF diagnosis1. – False-positive diagnosis in over 30%2, and false negative in over 20% of elderly COPD patients3. – There is marked variability, even among cardiologists, as to what findings are considered diagnostic for HF4. 1BMJ 2003;326(7382):196 2Eur Heart J 1991; 12: 315-321 3BMJ 2005; 26:1887-94 4J Am Coll Cardiol 1986;8:966-70 Heal • Teach • Discover • Serve
  • 3. Background • A better understanding of the time course of the earliest clinical manifestations of HF may help improve the earlier diagnosis of the HF patient. • The limited available data evaluating the onset of HF signs and symptoms have focused only on the days to weeks preceding an acute HF exacerbation. Am J Med. 2003;114:625–630 Heal • Teach • Discover • Serve
  • 4. Objective Identify the time course for the presentation of HF signs and symptoms in the months to years preceding a HF diagnosis through the application of a sophisticated natural language processing protocol to longitudinal EHRs in a large primary care population. Heal • Teach • Discover • Serve
  • 5. Methods • The dataset used for this project consisted of the full records for 50,625 patients followed in the primary care network of the GHS, consisting of 4,644 cases and 45,981 group-matched controls. • The features used for machine learning include assertions and denials of Framingham HF criteria. • Extracted by text mining tools consisting of a pipeline of dictionary, grammar and text analysis engines developed and deployed within the UIMA system. • In total, there are over 3.3 million clinical notes, with a total of 4,484,666 Framingham criteria mentions; 892,805 of these were affirmed criteria. Heal • Teach • Discover • Serve
  • 6. Methods – Framingham Criteria MAJOR SYMPTOMS MINOR SYMPTOMS 1. Paroxysmal Nocturnal Dyspnea 1. Bilateral Ankle Edema (PND) or Orthopnea 2. Neck Vein Distension (JVD) 2. Nocturnal Cough 3. Rales 3. Dyspnea on ordinary exertion 4. Radiographic Cardiomegaly 4. Hepatomegaly 5. Acute Pulmonary Edema 5. Pleural effusion 6. A decrease in vital capacity by 1/3 of 6. S3 Gallop the maximal value recorded 7. Increased Central Venous Pressure 7. Tachycardia (>120 BPM) (> 16 cm H2O at RA) 8. Circulation Time of 25 seconds * Not utilized in this analysis as not 9. Hepatojugular Reflux (HJR) documented in routine clinical 10.Weight loss 4.5kg in 5 days in practice. response to treatment Heal • Teach • Discover • Serve N Engl J Med. 1971;285:1441-1446.
  • 7. Results – Patient Characteristics Cases (N=4,644) Mean Age (years) 70.9 Female (%) 48.4 EF < 50% (%) 45.3 Hypertension (%) 61.9 Diabetes (%) 31.8 Known CAD (%) 25.5 Valvular Heart Disease (%) 4.2 COPD (%) 18.4 Chronic Kidney Disease (%) 4.4 Heal • Teach • Discover • Serve
  • 8. Results: Average Days Prior to Clinical Diagnosis of Criterion Documentation # of Patients in Whom Criteria Average # of Days were Identified Prior to Clinical Prior to Clinical Diagnosis Diagnosis Ankle Edema 3875 (83%) 238 PND 1691 (36%) 210 Dyspnea on 3840 (83%) 200 Exertion Rales 1410 (30%) 133 Radiographic 1207 (26%) 83 Cardiomegaly JVD 549 (12%) 77 Night Cough 374 (8%) 53 Tachycardia 409 (9%) 45 Pleural Effusion 772 (17%) 43 Hepatomegaly 246 (5%) 38 S3 Gallop 130 (3%) 18 Weight Loss 151 (3%) 15 Heal • Teach • Discover • Serve
  • 9. Results: Percentage of Patients with Select Criterion in the 4 Years Prior to Clinical Diagnosis Year 4 Year 3 Year 2 Year 1 70 Percent with Criterion Documented 65 60 62.3 Mean 238 Days Mean 50 200 Days 49.5 45.3 40 36.7 34 30 25.2 20 23.2 Mean Mean 17.9 210 Days 17.2 133 Days 10 11.3 10.1 8.4 7.3 6.2 5.2 0 Ankle Edema PND DOE Rales Heal • Teach • Discover • Serve
  • 10. Limitations • Text and data mining are not perfect in their ability to recognize and appropriately label Framingham criteria. (overall F-score ~0.93) • There is substantial variability in whether and how various clinicians document HF signs and symptoms. Heal • Teach • Discover • Serve
  • 11. Summary • This is the first study we are aware of to identify the prevalence and timing of onset of HF signs and symptoms in the months to years preceding a clinical HF diagnosis. • In many HF patients the signs and symptoms of HF are first documented well before clinical diagnosis; on average > 6 months. • These results suggest that automated text and data mining of the EHR may play an important role in the earlier identification of the HF patient in the primary care setting. Heal • Teach • Discover • Serve
  • 12. Ongoing Work: Matrix Presentation of Symptom / Sign Co-occurrence
  • 13. Ongoing Work: Outflow Graph of Relationships Between Different Criterion